CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) Heart Failure With Preserved Ejection Fraction in the Young Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association

Editorial2021 Jan 20;S0828-282X(21)00051-9.

JOURNAL:Can J Cardiol. Article Link

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

JG Howlett. Keywords: angiotensin receptor/neprilysin inhibitor; HF

Full Text PDF